Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant

Author:

Ghosh Nilanjan1,Ahmed Sairah2,Ahn Kwang Woo34,Khanal Manoj34,Litovich Carlos3,Aljurf Mahmoud5,Bacher Vera Ulrike6,Bredeson Christopher7,Epperla Narendranath8,Farhadfar Nosha9,Freytes César O.10,Ganguly Siddhartha11,Haverkos Bradley12,Inwards David13,Kamble Rammurti T.14,Lazarus Hillard M.15,Lekakis Lazaros16,Murthy Hemant S.17,Nishihori Taiga18,Ramakrishnan Praveen19,Rizzieri David A.20,Yared Jean A.21,Kharfan-Dabaja Mohamed A.17,Sureda Anna22,Hamadani Mehdi3

Affiliation:

1. Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina

2. Department of Myeloma and Lymphoma, University of Texas, MD Anderson Cancer Center, Houston

3. Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee

4. Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee

5. Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia

6. Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Switzerland

7. The Ottawa Hospital Blood and Marrow Transplant Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

8. Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus

9. Division of Hematology and Oncology, University of Florida College of Medicine, Gainesville

10. Texas Transplant Institute, San Antonio, Texas

11. Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City

12. Department of Medicine, University of Colorado Hospital, Aurora, Colorado

13. Division of Hematology, Mayo Clinic, Rochester, Minnesota

14. Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas

15. Department of Hematology and Oncology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio

16. Department of Medicine, University of Miami, Miami, Florida

17. Division of Hematology–Oncology, Blood and Marrow Transplantation Program, Mayo Clinic Florida, Jacksonville

18. Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida

19. Lymphoma, Bone Marrow Transplant and Cellular Therapy Program, UT Southwestern Medical Center, Dallas, Texas

20. Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina

21. Division of Hematology and Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, Blood and Marrow Transplantation Program, University of Maryland, Baltimore

22. Institut Català d'Oncologia–Hospitalet, Hematology Department, University of Barcelona, Barcelona, Spain

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3